Premier US and UK e-learning providers in the Life Sciences are to offer multinational pharmaceutical companies a single end-to-end solution for their enterprise knowledge needs.

San Francisco, CA and London, England, May 9th, 2005 - As major multinational pharmaceutical, biotechnology, medical device and agricultural companies continue to embrace e-learning as the primary method of increasing workforce productivity, GeneEd and Zenosis, the premier providers of Life Science e-learning in the US and Europe respectively, today announced that they have formed a strategic partnership to create a new product that will utilize their complementary platforms.

GeneEd, the leader in scientific and technical training, has teamed with Zenosis, the leader in regulatory and compliance training, to offer Life Science organizations a single, integrated system that combines the best content from each organization with the viewing, interactivity and management tools in order to offer users the most practical and extensive learning and knowledge transfer service. The range of pharmaceutical e-learning includes discovery and development tools (pharmacogenetics, proteomics, microarrays), regulatory and compliance training (GxPs, eCTD, adverse events, pharmacovigilance), sales force therapeutic area and disease-state training, manufacturing product scale-up and commercialization, and physician product education and patient education and outreach.

The combination of Zenosis' 'nano-training' - the delivery of required global regulatory and compliance directives and recommendations in a 'just-in-time' format - with GeneEd's scalable 'configured library', based upon the reusable learning object strategy developed in the software industry, stands in mark contrast to other e-learning vendors custom 'one-off' solutions that feature little scalability or reuse, in contrast to other companies that require pharmaceutical clients to adapt proprietary solutions. The success of the two companies' respective platforms is reflected in the rate of adoption of both the content libraries and the viewing and repurposing tools by over 50 customers world-wide, providing clients with the best combination of flexibility and user experience.

'Major global customers such as Amgen, Genentech, Pfizer and AstraZeneca can now benefit from a comprehensive library of e-learning' said Sunil Maulik, Ph.D., CEO of GeneEd. 'With the formation of this strategic partnership with Zenosis, we can help our clients circumvent the development, regulatory and sales hurdles they face in providing cutting-edge cures for human health.' Simon Burgess, CEO of Zenosis, concurred. 'With this product and distribution integration partnership we can provide clients a balanced viewpoint of the regulatory and compliance issues they face in the US, Europe and Asia,' he added.

The companies anticipate the first products from the integration effort to be available in the fourth quarter with a comprehensive solution-set available shortly thereafter.

GeneEd, Inc. was founded in 1997 to provide pharmaceutical and healthcare e-learning solutions for the pharmaceutical, biotechnology, instrument and medical device, and hospital/HMO industries. GeneEd's Life Science industry customers include AstraZeneca, Pfizer, Johnson & Johnson, Celera, Bio-Rad, and IBM Life Sciences, amongst many others.

GeneEd utilizes the best Life Science content, combined with advanced e-learning development technology, to rapidly create basic and advanced curricula in the areas of genomics, therapeutic area training (for clinical research, product development, and sales and marketing teams), computer assisted drug design, drug discovery and development, pharmacogenomics and clinical genomics, bioinformatics and microarray informatics, and therapeutic and diagnostic products. GeneEd, Inc. is a privately held company headquartered in San Francisco, California. Visit GeneEd.com for additional information.

Zenosis was established in 2002 to provide the global Life Science industry with comprehensive regulatory e-learning and knowledge building system that is always up-to-date and accessible, 24x365. After extensive test marketing to many of the global leaders in Pharmaceutical industry. Zenosis formally launched its ' web-based training' in November 2004 and has since received acclaim from many of the worlds leading Pharmaceutical companies who now actively use the 'Zenosis system' in Europe, USA and South East Asia, including AstraZeneca, Wyeth, Merck, Organon, Schering and Nycomed to name but a few.